These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 25416066

  • 1. Efficacy of oral methotrexate in paediatric Crohn's disease: a multicentre propensity score study.
    Turner D, Doveh E, Cohen A, Wilson ML, Grossman AB, Rosh JR, Lu Y, Bousvaros A, Deslandres C, Noble A, Baldassano RN, Levine A, Lerner A, Wilson DC, Griffiths AM.
    Gut; 2015 Dec; 64(12):1898-904. PubMed ID: 25416066
    [Abstract] [Full Text] [Related]

  • 2. Methotrexate for maintaining remission in paediatric Crohn's patients with prior failure or intolerance to thiopurines: a multicenter cohort study.
    Haisma SM, Lijftogt T, Kindermann A, Damen G, de Ridder L, Escher JC, Mearin ML, de Meij T, Hendriks D, George E, Hummel T, Norbruis O, van Rheenen P.
    J Crohns Colitis; 2015 Apr; 9(4):305-11. PubMed ID: 25656249
    [Abstract] [Full Text] [Related]

  • 3. Protocol for a multinational risk-stratified randomised controlled trial in paediatric Crohn's disease: methotrexate versus azathioprine or adalimumab for maintaining remission in patients at low or high risk for aggressive disease course.
    Harris RE, Aloi M, de Ridder L, Croft NM, Koletzko S, Levine A, Turner D, Veereman G, Neyt M, Bigot L, Ruemmele FM, Russell RK, PIBD SETQuality consortium and PIBDnet.
    BMJ Open; 2020 Jul 01; 10(7):e034892. PubMed ID: 32611737
    [Abstract] [Full Text] [Related]

  • 4. Methotrexate intolerance in oral and subcutaneous administration in patients with juvenile idiopathic arthritis: a cross-sectional, observational study.
    van Dijkhuizen EH, Pouw JN, Scheuern A, Hügle B, Hardt S, Ganser G, Kümmerle-Deschner JB, Horneff G, Holzinger D, Bulatović Ćalasan M, Wulffraat NM.
    Clin Exp Rheumatol; 2016 Jul 01; 34(1):148-54. PubMed ID: 26843067
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetic profiles for oral and subcutaneous methotrexate in patients with Crohn's disease.
    Wilson A, Patel V, Chande N, Ponich T, Urquhart B, Asher L, Choi Y, Tirona R, Kim RB, Gregor JC.
    Aliment Pharmacol Ther; 2013 Feb 01; 37(3):340-5. PubMed ID: 23190184
    [Abstract] [Full Text] [Related]

  • 6. European experience with methotrexate treatment in Crohn's disease: a multicenter retrospective analysis.
    Kopylov U, Katsanos KH, van der Woude CJ, Karmiris K, Hernandez V, Odes S, Papamichael K, Koutroubakis IE, Bojic D, Kaimakliotis I, Fiorino G, Papageorgiou N, Pineda JR, Strongili K, Sanroman L, Mantzaris GJ, Jojic N, Paspatis G, Christodoulou DK, Ben-Horin S, Tsianos EV.
    Eur J Gastroenterol Hepatol; 2016 Jul 01; 28(7):802-6. PubMed ID: 26894634
    [Abstract] [Full Text] [Related]

  • 7. Methotrexate for maintenance of remission in Crohn's disease.
    Patel V, Wang Y, MacDonald JK, McDonald JW, Chande N.
    Cochrane Database Syst Rev; 2014 Aug 26; 2014(8):CD006884. PubMed ID: 25157445
    [Abstract] [Full Text] [Related]

  • 8. A single center experience of methotrexate in the treatment of Crohn's disease and ulcerative colitis: a case for subcutaneous administration.
    Nathan DM, Iser JH, Gibson PR.
    J Gastroenterol Hepatol; 2008 Jun 26; 23(6):954-8. PubMed ID: 17559377
    [Abstract] [Full Text] [Related]

  • 9. Methotrexate treatment in pediatric Crohn disease patients intolerant or resistant to purine analogues.
    Weiss B, Lerner A, Shapiro R, Broide E, Levine A, Fradkin A, Bujanover Y.
    J Pediatr Gastroenterol Nutr; 2009 May 26; 48(5):526-30. PubMed ID: 19412004
    [Abstract] [Full Text] [Related]

  • 10. Methotrexate is an efficient therapeutic alternative in children with thiopurine-resistant Crohn's disease.
    Hojsak I, Mišak Z, Jadrešin O, Močić Pavić A, Kolaček S.
    Scand J Gastroenterol; 2015 May 26; 50(10):1208-13. PubMed ID: 25877164
    [Abstract] [Full Text] [Related]

  • 11. Retrospective cohort study of methotrexate use in the treatment of pediatric Crohn's disease.
    Sunseri W, Hyams JS, Lerer T, Mack DR, Griffiths AM, Otley AR, Rosh JR, Carvalho R, Grossman AB, Cabrera J, Pfefferkorn MD, Rick J, Leleiko NS, Hitch MC, Oliva-Hemker M, Saeed SA, Kappelman M, Markowitz J, Keljo DJ, Pediatric Inflammatory Bowel Disease Collaborative Research Group.
    Inflamm Bowel Dis; 2014 Aug 26; 20(8):1341-5. PubMed ID: 24983976
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of methotrexate in pediatric Crohn's disease: a French multicenter study.
    Uhlen S, Belbouab R, Narebski K, Goulet O, Schmitz J, Cézard JP, Turck D, Ruemmele FM.
    Inflamm Bowel Dis; 2006 Nov 26; 12(11):1053-7. PubMed ID: 17075346
    [Abstract] [Full Text] [Related]

  • 13. Increased effectiveness of early therapy with anti-tumor necrosis factor-α vs an immunomodulator in children with Crohn's disease.
    Walters TD, Kim MO, Denson LA, Griffiths AM, Dubinsky M, Markowitz J, Baldassano R, Crandall W, Rosh J, Pfefferkorn M, Otley A, Heyman MB, LeLeiko N, Baker S, Guthery SL, Evans J, Ziring D, Kellermayer R, Stephens M, Mack D, Oliva-Hemker M, Patel AS, Kirschner B, Moulton D, Cohen S, Kim S, Liu C, Essers J, Kugathasan S, Hyams JS, PRO-KIIDS Research Group.
    Gastroenterology; 2014 Feb 26; 146(2):383-91. PubMed ID: 24162032
    [Abstract] [Full Text] [Related]

  • 14. Methotrexate for maintenance of remission in Crohn's disease.
    Patel V, Macdonald JK, McDonald JW, Chande N.
    Cochrane Database Syst Rev; 2009 Oct 07; (4):CD006884. PubMed ID: 19821390
    [Abstract] [Full Text] [Related]

  • 15. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW, Tsoulis DJ, Macdonald JK, Feagan BG.
    Cochrane Database Syst Rev; 2012 Dec 12; 12():CD003459. PubMed ID: 23235598
    [Abstract] [Full Text] [Related]

  • 16. Methotrexate in the treatment of inflammatory bowel disease: an 8-year retrospective study in a Canadian pediatric IBD center.
    Willot S, Noble A, Deslandres C.
    Inflamm Bowel Dis; 2011 Dec 12; 17(12):2521-6. PubMed ID: 21337668
    [Abstract] [Full Text] [Related]

  • 17. Methotrexate in patients with Crohn's disease after 6-mercaptopurine.
    Mack DR, Young R, Kaufman SS, Ramey L, Vanderhoof JA.
    J Pediatr; 1998 May 12; 132(5):830-5. PubMed ID: 9602195
    [Abstract] [Full Text] [Related]

  • 18. The comparative effectiveness of oral versus subcutaneous methotrexate for the treatment of early rheumatoid arthritis.
    Hazlewood GS, Thorne JC, Pope JE, Lin D, Tin D, Boire G, Haraoui B, Hitchon CA, Keystone EC, Jamal S, Bykerk VP, CATCH Investigators.
    Ann Rheum Dis; 2016 Jun 12; 75(6):1003-8. PubMed ID: 25979945
    [Abstract] [Full Text] [Related]

  • 19. Differences in Outcomes Over Time With Exclusive Enteral Nutrition Compared With Steroids in Children With Mild to Moderate Crohn's Disease: Results From the GROWTH CD Study.
    Cohen-Dolev N, Sladek M, Hussey S, Turner D, Veres G, Koletzko S, Martin de Carpi J, Staiano A, Shaoul R, Lionetti P, Amil Dias J, Paerregaard A, Nuti F, Pfeffer Gik T, Ziv-Baran T, Ben Avraham Shulman S, Sarbagili Shabat C, Sigall Boneh R, Russell RK, Levine A.
    J Crohns Colitis; 2018 Feb 28; 12(3):306-312. PubMed ID: 29165666
    [Abstract] [Full Text] [Related]

  • 20. Growth and bone health in paediatric patients with Crohn's disease receiving subcutaneous tumor necrosis factor antibody.
    Pichler J, Huber WD, Aufricht C, Bidmon-Fliegenschnee B.
    World J Gastroenterol; 2015 Jun 07; 21(21):6613-20. PubMed ID: 26074699
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.